These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 9399748

  • 1. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 2. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G.
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [Abstract] [Full Text] [Related]

  • 3. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Oyasu K, Wakamatsu T, Sumitomo Y, Kiyota K, Inokuchi H, Kawai K.
    Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
    [Abstract] [Full Text] [Related]

  • 4. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM, Gerrity MS, Anderson T.
    Eff Clin Pract; 2001 Sep; 4(6):263-70. PubMed ID: 11769299
    [Abstract] [Full Text] [Related]

  • 5. PPIs vs H2RAs for erosive reflux esophagitis.
    King VJ.
    J Fam Pract; 1998 Mar; 46(3):199-200. PubMed ID: 9519012
    [No Abstract] [Full Text] [Related]

  • 6. Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
    Ofman JJ, Yamashita BD, Siddique RM, Larson LR, Willian MK.
    Am J Manag Care; 2000 Aug; 6(8):905-16. PubMed ID: 11186502
    [Abstract] [Full Text] [Related]

  • 7. Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition.
    Harris RA, Kuppermann M, Richter JE.
    Am J Med; 1997 Jan; 102(1):78-88. PubMed ID: 9209204
    [Abstract] [Full Text] [Related]

  • 8. "Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.
    Habu Y, Maeda K, Kusuda T, Yoshino T, Shio S, Yamazaki M, Hayakumo T, Hayashi K, Watanabe Y, Kawai K.
    J Gastroenterol; 2005 Nov; 40(11):1029-35. PubMed ID: 16322946
    [Abstract] [Full Text] [Related]

  • 9. [Cost-effectiveness analysis for the treatment of non-erosive reflux disease].
    Habu Y, Fukui Y, Maruno T, Hisatsune H, Kawai K.
    Nihon Rinsho; 2007 May; 65(5):951-5. PubMed ID: 17511239
    [Abstract] [Full Text] [Related]

  • 10. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM, Dulai GS, Lim BS, Mann N, Kanwal F, Gralnek IM.
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [Abstract] [Full Text] [Related]

  • 11. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
    Arguedas MR, Heudebert GR, Klapow JC, Centor RM, Eloubeidi MA, Wilcox CM, Spechler SJ, VA Cooperative Study Group.
    Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Yoshino T, Shio S, Hayakumo T, Kawai K.
    Nihon Rinsho; 2004 Aug; 62(8):1504-9. PubMed ID: 15344541
    [Abstract] [Full Text] [Related]

  • 13. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM, McIntyre L, Bernard L, Fendrick AM.
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [Abstract] [Full Text] [Related]

  • 14. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 15. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 16. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 17. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 Apr; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 18. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF.
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [Abstract] [Full Text] [Related]

  • 19. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Jul; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 20. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
    Ofman J, Wallace J, Badamgarav E, Chiou CF, Henning J, Laine L.
    Am J Gastroenterol; 2002 Aug; 97(8):1941-50. PubMed ID: 12190158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.